3,182 hedge funds and large institutions have $196B invested in Pfizer in 2022 Q1 according to their latest regulatory filings, with 156 funds opening new positions, 1,374 increasing their positions, 1,338 reducing their positions, and 183 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

12% less capital invested

Capital invested by funds: $222B → $196B (-$25.8B)

15% less first-time investments, than exits

New positions opened: 156 | Existing positions closed: 183

34% less funds holding in top 10

Funds holding in top 10: 249165 (-84)

Holders
3,182
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
165
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.18B
Puts
$3.23B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
76
$344M
77
$342M
78
$342M
79
$324M
80
$314M
81
$311M
82
$298M
83
$280M
84
$274M
85
$273M
86
$267M
87
$257M
88
$243M
89
$240M
90
$238M
91
$238M
92
$232M
93
$232M
94
$230M
95
$228M
96
$225M
97
$221M
98
$218M
99
$217M
100
$203M